Report of the GUDID Clinically Relevant Size (CRS) Work Group

By AHRMM

Related Resources

Case Studies
Leading Practice: Reduction of Costs Related to Blood Products and Services - University of Pittsburgh Medical Center
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
Leading Practice: Reduction or Elimination of CAUTI - Nexera, Inc.
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Advisory
Statement on Pricing Transparency
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Issue Brief
Medical Device Excise Tax - What You Should Know
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
Toolkits/Methodology
Strategic Marketplace Initiative (SMI) Resources for Supply Chain
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply ch